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Abstract
Objective. Prescribing of broad spectrum antibiotics and antidepressants in general practice often does not accord with guidelines. 
The aim was to determine the effectiveness of educational outreach in improving the prescribing of selected antibiotics and 
antidepressants, and whether the effect is sustained for two years.  Design. Single blind randomized trial.  Setting. Twenty-eight 
general practices in Leicestershire, England.  Intervention. Educational outreach visits were undertaken, tailored to barriers to 
change, 14 practices receiving visits for reducing selected antibiotics and 14 for improving antidepressant prescribing.  Main outcome 
measures. Number of items prescribed per 1000 registered patients for amoxicillin with clavulanic acid (co-amoxiclav) and quinolone 
antibiotics, and average daily quantities per 1000 patients for lofepramine and fl uoxetine antidepressants, measured at the practice 
level for six-month periods over two years.  Results. There was no effect on the prescribing of co-amoxiclav, quinolones, or fl uoxetine, 
but prescribing of lofepramine increased in accordance with the guidelines. The increase persisted throughout two years of 
follow-up.  Conclusion. A simple, group-level educational outreach intervention, designed to take account of identifi ed barriers to 
change, can have a modest but sustained effect on prescribing levels. However, outreach is not always effective. The context in
which change in prescribing practice is being sought, the views of prescribers concerning the value of the drug, or other unrecognised 
barriers to change may infl uence the effectiveness of outreach. 
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Educational outreach is a strategy in which a trained 
person meets with providers in their setting to give 
information with the intention of changing the pro-
vider’s practice [1 ]. It can lead to modest improve-
ments in care processes and can be delivered to 
individual providers or groups, but the value of the 
method in routine practice depends on the duration 
of its effect [ 1–4]. 
Antimicrobial resistance is a signifi cant problem 
[5]. Current national guidance in England, consistent 
with guidance at the time of our study (2002–2004), 
advises the prescription of an antibiotic only when 
it is likely to have clinical benefi t and the avoidance 
of broad-spectrum antibiotics such as amoxicillin 
with clavulanic acid (co-amoxiclav) or quinolones 
since they increase the risk of resistant infections [6 ]. 
Educational outreach can be effective in 
improving prescribing practice, but the specifi c 
methods of outreach and the duration of the 
effect are uncertain.
An outreach intervention, tailored to address •
barriers to change, was effective in improv-
ing antidepressant prescribing, the effect 
persisting for two years.
There was no improvement, however, in the •
prescribing of broad-spectrum antibiotics.
For some drugs, or in some contexts, bar-•
riers to improved prescribing may be either 
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antibiotics. Prior to outreach visits, the outreach 
visitor (A E-P) received training in academic detail-
ing and undertook semi-structured interviews of four 
volunteer non-study general practitioners to identify 
barriers to the appropriate prescribing of antidepres-
sants and broad-spectrum antibiotics. The fi ndings 
of the interviews were used to tailor the intervention 
to the barriers, including the content of the educa-
tional packages and the discussions during the out-
reach visits. The intervention was then piloted with 
two other non-study general practitioners. 
The practices were visited between May and 
November 2002. The visits lasted 20 to 40 minutes, 
and were attended by all doctors with prescribing 
responsibilities at the practice. Practices were blind 
to the fact that they were also serving as controls 
for the non-intervention drugs. The intervention 
was carried out at group level with interactive dis-
cussion of the supporting evidence for appropriate 
prescribing, perceived barriers to change, and best 
methods to overcome them. Practices were pre-
sented with their baseline prescribing data in com-
parison with the range of prescribing for all local 
practices. The prescribing information was itemised 
per class of antibiotic or antidepressant, and a copy 
was given to each doctor. Doctors were also given an 
antidepressant-prescribing fl ow chart or guidelines 
for the management of common infections in primary 
care, according to study group. Before leaving the 
practice, agreement was sought from the doctors 
that they would modify their prescribing as advised. 
The outreach visitor made structured notes after each
visit on the doctors’ reactions and whether they 
agreed to implement the prescribing recommenda-
tions. A second visit to each of the practices was 
carried out six months later to provide feedback on 
prescribing patterns and clarify outstanding issues. 
The prescribing data were retrieved from a nation-
ally available database [21 ] that provides information 
to health service managers and practices, itemized as 
follows: prescription rates per 1000 patients regis-
tered with the practice for co-amoxiclav and quino-
lones; prescription rates per 1000 registered patients 
for all antibiotics; average daily quantities (ADQs) 
per 1000 patients for lofepramine and fl uoxetine; 
and ADQs for all tricyclics and all SSRIs. The ADQ 
is a measure of prescribing volume based on pre-
scribing behaviour in England and represents the 
assumed average maintenance dose per day for a 
drug used for its main indication in adults [22 ]. The 
ADQ per patient is 140 mgm for lofepramine and 
20 mgm for fl uoxetine. The prescribing data did not 
identify which patients in the participating practices 
had received prescriptions and did not differentiate 
between prescriptions for new courses of treatment 
or for continuing treatment. 
Current English guidelines on the management of 
depression recommend selective serotonin reuptake 
inhibitors (SSRI) because they are less likely to be 
discontinued and are as effective as tricyclics [7 ]. 
At the time of our study, local guidelines recom-
mended lofepramine (a tricyclic antidepressant) as 
fi rst choice [8 ]. 
Tailoring interventions to address identifi ed bar-
riers may improve effectiveness [9 ]. Barriers may 
exist at the level of the individual health professional, 
the team, or the organization [10 ,11], but evidence 
on which interventions are effective in addressing 
specifi c barriers is limited [9 ]. Educational interven-
tions to improve antibiotic prescribing appear prom-
ising [3 ,12,13]. Barriers to appropriate antibiotic 
prescribing include concern about complications and 
maintenance of the doctor–patient relationship [14 ], 
and organizational context [15 ,16]. Lack of confi -
dence in counselling patients about the side-effects 
of antidepressants can be a barrier to prescribing 
therapeutic doses [17 ]. Few studies address the ques-
tion of whether the effects of outreach visits persist, 
follow-up being short in most trials [2 ,13,18]. In this 
two-year follow-up study, we investigated the impact 
of a tailored educational outreach intervention aimed 
at reducing the prescribing of broad-spectrum anti-
biotics, and increasing the prescribing of lofepramine 
and fl uoxetine. 
Material and methods 
The study took place in Leicestershire, central 
England. All local general practices (n  151) were 
invited to participate by post in February 2002. 
Twenty-eight practices agreed; all completed the 
study ( Figure 1 ).
We conducted a randomized controlled trial with 
randomization, intervention, and analysis at the level 
of the practice. Practices were randomized to two 
groups using a table of random numbers. To account 
for variability in initial levels of prescribing of 
broad-spectrum antibiotics, randomization was strat-
ifi ed to ensure each study group included similar 
numbers of practices with prescribing of quinolones 
and co-amoxiclav above and below the median of 
the 28 included practices at baseline. One group of 
practices received an intervention for antidepressant 
prescribing and served as controls for antibiotic pre-
scribing, and the other group received an interven-
tion for antibiotic prescribing and served as controls 
for antidepressant prescribing [19 ]. 
The intervention was an educational outreach 
visit based on the principles of academic detailing 
[20]. Two educational packages were developed 
that included summaries of current evidence on the 
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at practice and not patient level. Consequently, the 
study was not a cluster randomized design [19 ]. The 
sample size was suffi cient to detect a difference of 1.8 
items per 1000 patients for antibiotic prescribing and 
20 ADQs per 1000 patients for antidepressants, with 
5% signifi cance and 80% power. Descriptive statis-
tics were used to determine whether the two groups 
of practices had similar characteristics. 
Two consecutive six-month periods were used to 
establish baseline prescribing levels before the inter-
ventions to account for possible seasonal variations 
in prescribing. Since there were no differences in 
prescribing rates between these two periods we have 
used the mean of the two periods to indicate baseline 
prescribing. To analyse the rate- and count-based 
Information was obtained on number of doctors 
in each practice, socioeconomic deprivation among 
practice patient populations using a standard index 
[23], and patient list size by age group and gender. 
The study outcomes were number of items prescribed 
for each six-month study period per 1000 patients by 
practice for co-amoxiclav and quinolone antibiotics, 
and the number for each six-month study period of 
average daily quantities (ADQs) per 1000 registered 
patients by practice for lofepramine and fl uoxetine 
antidepressants at six, 12, 18, and 24 months after 
the fi rst outreach visit. 
Randomization, delivery of the intervention and 
analysis were all done at the practice level. The pre-
scribing data used in the study described prescribing 
Figure 1. Study fl owchart.
Assessed for eligibility
(n  151 practices)
Refused to participate (n  123)
Analysed (n  14) 
Lost to follow-up (n  0)
Discontinued intervention
(n  0)
Allocated to outreach on antibiotics 
(n  14) 
Received allocated intervention 
(n  14) 
Lost to follow-up  (n  0)
Discontinued intervention
(n  0)
Allocated to outreach on
antidepressants
(n  14) 
Received allocated 
intervention
(n  14) 
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munity, and concern by the doctor to treat a patient 
with comorbid conditions effectively. Barriers to 
appropriate antidepressant prescribing included habit, 
the prescribing policy of the local psychiatrists, and 
cost. Most doctors welcomed the guidance and did 
not challenge the evidence, but some saw the interven-
tion as criticism of their prescribing. At the end of the 
fi rst outreach visits, six practices in the antidepressant 
group and seven in the antibiotic group gave a fi rm 
commitment to change their prescribing. 
Negative binomial regression analysis for each six-
month period did not identify any consistent changes 
in antibiotic or antidepressant prescribing (detailed 
results not shown). The mixed-effects negative bino-
mial regression model with identity link to detect 
impact over the 24-month period of follow-up on 
absolute levels of prescribing indicated an effect on 
lofepramine prescribing (rate ratio 2.85, p  0.001, 
Table II ). There was no effect on co-amoxiclav, qui-
nolone, or fl uoxetine prescribing.  Table III presents 
regression models adjusted for baseline prescribing 
of the target antibiotics combined as a percentage of 
all antibiotic prescriptions, and target antidepressants 
as a percentage of all antidepressants. The propor-
tion of target antibiotics prescribed was not signifi -
cantly lower at any review point, but the proportion 
of target antidepressants prescribed was higher in the 
intervention group in the last three review periods 
up to 24 months. 
Discussion
Principal fi ndings 
There was a small change in the desired direction 
in the proportion of antidepressants prescribed 
according to guidelines that lasted for 24 months, 
data we used Poisson regression [24 ] and tested for 
goodness-of-fi t in terms of over-dispersion using the 
deviance based Chi-square test. For all study vari-
ables, the Chi-square p values were highly signifi cant 
suggesting over-dispersion. Consequently we used 
Negative Binomial regression models [24 ] to assess 
the effect of the intervention, having adjusted for the 
baseline effect. These analyses were done separately 
for every six-month period. The appropriate diag-
nostic criteria were used, including the likelihood 
ratio test to assess the fi ts. The overall effect of the 
interventions was also examined combining outcome 
measurements over all review periods and baseline 
measurements, using a generalized mixed-effects 
model based on Negative Binomial distributions. To 
assess the effect of the intervention on the targeted 
antibiotics as a percentage of all antibiotics pre-
scribed, and the targeted antidepressants as a per-
centage of all antidepressants prescribed, we used 
robust linear regression techniques, adjusting for 
baseline, to account for the problem of heterosce-
dasticity and non-normality. All statistical analyses 
were conducted using STATA 8 software. 
Results
Practice characteristics are given in  Table I . Three 
practices in the antibiotic group were accredited to 
train residents (trainees), and two in the antidepres-
sant group. Practices in the antidepressant intervention 
group were smaller, although patient socioeconomic 
status was similar. The interviews indicated that bar-
riers to appropriate antibiotic prescribing included 
failure of a narrow-spectrum antibiotic to be effec-
tive, doctor and patient attitude towards risk, lack of 
information on the sensitivity of bacteria in the com-
Table I. Baseline characteristics of study practices by intervention group (items per patient – numbers of prescriptions in six-month period 
per 1000 registered patients; ADQ per 1000 patients – average daily quantities [the assumed average maintenance dose per day] in six-
month period per 1000 patients).
Antibiotic intervention group 
(n 14) Mean (95% CI)
Antidepressant intervention group 
(n 14) Mean (95% CI) p
Number of GPs per practice 3.3 (2.2, 4.5) 2.2 (1.4, 2.9) 0.08
Patients per practice 
  Females 0–18 years 930 (279, 1124) 424 (279, 580) 0.06
  Females 19–65 years 2261 (857, 3198) 1156 (670, 1799) 0.15
  Females 66 + years 693 (296, 899) 266 (164, 367) 0.06
  Males 0–18 years 974 (317, 1159) 469 (308, 604) 0.06
  Males 19–65 years 2088 (978, 3275) 1119 (670, 1768) 0.33
  Males 66 + years 449 (219, 671) 194 (136, 282) 0.06
  ID2004 Deprivation Score 20.6 (14.3, 26.8) 23.3 (16.2, 30.3) 0.46
Co-amoxiclav items per 1000 patients 10.9 (6.6, 15.2) 8.0 (4.4, 11.6) 0.31
Quinolone items per 1000 patients 11.4 (5.1, 17.8) 8.0 (5.2, 10.7) 0.38
Lofepramine ADQs per 1000 patients 256.4 (195.9, 316.8) 252.7 (109.4, 396.1) 0.36
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a factor that may have reduced the ability to detect 
a rapid effect of the intervention on antidepressant 
prescribing. Nevertheless, the study provides fur-
ther evidence about the role of tailored outreach to 
infl uence clinical practice. 
Implications 
It is not clear why the outreach intervention infl u-
enced the prescribing of antidepressants but not of 
antibiotics. The context in which the participating 
practices were making prescribing decisions may 
have played a part in facilitating changes in anti-
depressant prescribing but not antibiotic prescrib-
ing; in other settings and circumstances, context 
may play a different or even contrary role. Despite 
the clear statements about effectiveness contained 
in the guidelines, doctors’ continued perceptions 
of clinical effectiveness, and desire for prompt 
benefi t [25 ], may have played a part in explaining 
the impact of the outreach intervention. Doctors 
in the study had expressed concern about reduced 
clinical effectiveness if they did not use broad-
spectrum antibiotics. However, doctors did not 
express doubts about the effectiveness of the rec-
ommended antidepressants. In a review of trials of 
interventions to improve antibiotic prescribing, edu-
cational outreach was found to have mixed results, 
although multi-faceted educational interventions 
applied after addressing barriers to change were 
more likely to be successful than other approaches 
[3]. Our fi ndings are consistent with this conclusion, 
and also with the fi nding that educational outreach 
has relatively small effects on prescribing [2 ]. Our 
study shows that these effects can be relatively long 
lasting. 
although no change for antibiotics. A simple, group-
level educational outreach intervention, designed to 
take account of identifi ed barriers to change, appears 
to have a small sustained effect on prescribing 
levels, but the effect is not consistent across different 
groups of drugs. The degree of effectiveness is likely 
to depend on the context, including the prevailing 
barriers to change, the clinical topic concerned, and 
the particular change being sought. 
Strengths and weaknesses of the study 
The study was a randomised trial with a carefully 
planned and delivered intervention and two years 
of follow-up, but there are a number of limitations. 
Only 28 practices were included, and only a limited 
proportion of practices in the locality agreed to par-
ticipate, raising concern about the external validity 
of the fi ndings. It is possible, for example, that the 
barriers to changing prescribing would be different 
in other practices. The prescribing data did not dif-
ferentiate between new and continuing prescriptions, 
Table III. Percentage of co-amoxiclav and quinolones prescribed as a proportion of total antibiotic (number of items per 1000 patients), 
and lofepramine and fl uoxetine as a proportion of total antidepressant prescribing (ADQs per 1000 patients).
Antibiotic group Mean (CI) Antidepressant group Mean (CI) p-values
Co-amoxiclav and quinolones as percentage of total
    antibiotic prescribing
Average baseline 6.9 (4.6, 9.0) 5.8 (3.1, 8.3)
Review 1 4.6 (3.3, 5.9) 6.2 (3.7, 8.8) 0.40
Review 2 5.7 (4.2, 7.2) 6.2 (3.7, 8.7) 0.43
Review 3 5.4 (4.30, 6.4) 6.8 (4.0, 9.5) 0.97
Review 4 5.8 (4.3, 7.3) 6.4 (3.8, 9.0) 0.98
Lofepramine and fl uoxetine as percentage of total
    antidepressant prescribing
Average baseline 20.9 (16.8, 25.1) 26.7 (22.6, 30.9)
Review 1 21.4 (17.3, 25.4) 27.7 (22.2, 33.2) 0.07
Review 2 21.3 (17.3, 25.3) 29.5 (24.0, 351) 0.01
Review 3 20.7 (16.6, 24.8) 29.4 (24.3, 34.5) 0.01
Review 4 20.8 (16.5, 25.2) 28.6 (23.0, 34.2) 0.01
Notes: Regression analysis adjusting for baseline. Review periods 1 to 4 were consecutive six-month periods, total follow up 24 months.
Table II. Effect of intervention combining data on all review 
periods using generalized mixed-effect model based on negative 
binomial regression distributions, with adjustment for baseline. 
Antibiotic prescribing – items per 1000 patients, antidepressant 
prescribing – average daily quantities.
Drug RRa  95% CI of RR    p
Co-amoxiclav 0.89   0.52, 1.50      0.65
Quinolones 0.98   0.63, 1.53      0.92
Lofepramine 2.85   1.92, 4.34     0.001
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The interviews undertaken to identify barriers to 
inform the design of the intervention indicated that 
prescribing of antibiotics was infl uenced by contex-
tual factors such as lack of information on drug resis-
tance or concern to treat patients with comorbidity 
effectively [14 ,26], and the doctor’s and patient’s 
perception of risk. In contrast, antidepressant pre-
scribing appeared to be infl uenced more commonly 
by habit rather than concern about effectiveness. It is 
possible that placing greater emphasis on the safety 
of avoiding broad-spectrum antibiotics would have 
given general practitioners the confi dence to apply 
the guidelines. 
Although half the practices expressed agreement 
with the recommendations on antibiotic prescrib-
ing, they did not change their prescribing habits. The 
method of educational outreach includes seeking 
agreement from the participating doctors to change 
their practice as recommended, but our study sug-
gests this is not a suffi cient guide as to whether the 
barriers have been overcome [20 ]. We used a rela-
tively simple method of exploring the barriers to rec-
ommended prescribing, but the methods generally 
used to identify barriers and to tailor interventions 
to overcome them are not yet well developed [9 ]. 
Research is required to develop and evaluate alterna-
tive approaches to barriers analysis, and to check with 
participants whether barriers have been addressed 
before discontinuing interventions and moving on to 
collect performance data. 
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